Decisions on investing in health as well as other policies require deciding how to best allocate available resources - recognizing that using labor, materials, and other resources for one purpose means that they cannot be used for other purposes. Approaches for economic evaluation, including...

The high cost of capital for firms conducting medical research and development (R&D) has been partly attributed to the government risk facing investors in medical innovation. This risk slows down medical innovation because investors must be compensated for it. We propose new and simple financial...

This paper provides new evidence that preventive health care services delivered at schools and provided at a relatively low cost have positive and lasting impacts. We use variation from a 1999-reform in Norway that induced substantial differences in the availability of health professionals...